Gennova Biopharmaceuticals Limited - Company Profile

It is a life sciences public limited company based in Pune City, Maharashtra, India, established in 2001.
2001 Pune City, Maharashtra, India Active
Last Updated:
Access Report
About Gennova Biopharmaceuticals Limited

Gennova Biopharmaceuticals Limited, a active public limited company, was established on 19 June 2001 in Pune City, Maharashtra, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: U24231PN2001PLC016253. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹65.00 Cr and a paid-up capital of ₹5.51 Cr.

Formerly known as Emcure Dragon Biotech Limited. It upholds a compliant status. Employing 705 professional, Its leadership includes Shailesh Kripalu Ayyangar (Director), Sanjay Singh (Ceo), Vikas Madan Thapar (Additional Director). Past directors included Shailesh Kripalu Ayyangar, Girish Laxmikant Telang, Sachin Kaushik. It holds ₹212.90 Cr open charges and ₹133.73 Cr settled loans. Its latest AGM occurred on 28 August 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. P-1 & P-2,, It-Bt Park, Phase - Ii, M.I.D.C., Pune City, Maharashtra, 411057.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231PN2001PLC016253

  • Registration Number

    016253

  • Incorporation Date

    19 June 2001

  • Authorized Capital

    ₹65.00 Cr

  • Paid-Up Capital

    ₹5.51 Cr

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 65.00 Cr
  • Paid Up Capital ₹ 5.51 Cr
  • Company Age 24 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 212.90 Cr
  • Satisfied Charges ₹ 133.73 Cr
  • Revenue Growth **** 9.75%
  • Profit Growth **** 83.26%
  • Ebitda **** 42.20%
  • Net Worth 16.50%
  • Total Assets **** 14.08%
Company report

Gennova Biopharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Gennova Biopharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Gennova Biopharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Shailesh Kripalu Ayyangar Director 26 Jul 2021 Current
Sanjay Singh Ceo 27 Oct 2020 Current
Vikas Madan Thapar Additional Director 07 Nov 2024 Current
Kavita Singh Director 24 Jan 2023 Current
Samit Satish Mehta Whole-Time Director 09 Sep 2011 Current
Sunil Rajanikant Mehta Director 19 Jun 2001 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Jul 2021 Past
Pramod Abcsdd Director 12 Sep 2018 Past
Pramod Abcsdd Cfo(Kmp) - Past
Pramod Abcsdd Director 27 Jul 2021 Past
Pramod Abcsdd Director 18 May 2009 Past
Pramod Abcsdd Additional Director 19 Aug 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gennova Biopharmaceuticals.

Gennova Biopharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.75% increase. The company also saw a substantial improvement in profitability, with a 83.26% increase in profit. The company's net worth Soared by an impressive increase of 16.5%.

Gennova Biopharmaceuticals revenue growth over time
Gennova Biopharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 9.75%
*******
*******
*******
*******
Revenue from Operations
*******
 9.63%
*******
*******
*******
*******
Total Assets
*******
 14.08%
*******
*******
*******
*******
Profit or Loss
*******
 83.26%
*******
*******
*******
*******
Net Worth
*******
 16.50%
*******
*******
*******
*******
EBITDA
*******
 42.20%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gennova Biopharmaceuticals?

In 2023, Gennova Biopharmaceuticals had a promoter holding of 87.95% and a public holding of 12.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,129,000,000.00

Satisfied Charges

₹1,337,324,709.00

Charges Breakdown by Lending Institutions
  • Others : 107.00 Cr
  • Axis Bank Limited : 55.90 Cr
  • Citi Bank N.A. : 50.00 Cr
Latest Charge Details
Date Lender Amount Status
30 Oct 2022 Citi Bank N.A. ₹50.00 Cr Open
20 May 2022 Axis Bank Limited ₹55.00 Cr Open
02 Sep 2021 Others ₹107.00 Cr Open
30 Jun 2021 Axis Bank Limited ₹9.00 M Open
25 Jun 2021 Others ₹22.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Gennova Biopharmaceuticals?

Gennova Biopharmaceuticals has a workforce of 705 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gennova Biopharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gennova Biopharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gennova Biopharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Gennova Biopharmaceuticals Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Gennova Biopharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was documented.

  • Director Appointment

    Progress on Vikas Madan Thapar was appointed as a Additional Director was appointed as a Additional Director on 07 Nov 2024 & has been associated with this company since 1 year 3 months . was documented.

  • Charges

    The activity A charge with Others of Rs. 107.00 Cr registered on 02 Sep 2021 with Charge ID 100483894 was modified on 07 Mar 2024. was completed.

  • Charges

    Progress on A charge registered on 11 Jan 2017 via Charge ID 100126176 with Others was fully satisfied on 28 Feb 2024. was documented.

  • Charges

    A charge registered on 30 Jun 2004 via Charge ID 90086867 with The Bank Of Maharashtra Limited was fully satisfied on 28 Feb 2024. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Gennova Biopharmaceuticals Limited?

The CIN of Gennova Biopharmaceuticals Limited is U24231PN2001PLC016253.

Where is Gennova Biopharmaceuticals Limited headquartered?

Gennova Biopharmaceuticals Limited is headquartered at Plot No. P-1 & P-2,, It-Bt Park, Phase - Ii, M.I.D.C., Pune City, Maharashtra, 411057.

When was Gennova Biopharmaceuticals Limited incorporated?

Gennova Biopharmaceuticals Limited was incorporated on 19 June 2001.

Who are the current directors of Gennova Biopharmaceuticals Limited?

The current directors of Gennova Biopharmaceuticals Limited are

What is the primary industry of Gennova Biopharmaceuticals Limited?

The primary industry of Gennova Biopharmaceuticals Limited is Manufacturing.

Is Gennova Biopharmaceuticals Limited a listed company?

Gennova Biopharmaceuticals Limited is unlisted.

What is the capital structure of Gennova Biopharmaceuticals Limited?

The authorized capital of Gennova Biopharmaceuticals Limited is ₹65.00 Cr, and the paid-up capital is ₹5.51 Cr.

What is the compliance status of Gennova Biopharmaceuticals Limited?

The compliance status of Gennova Biopharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available